We are live on ! Find out more
RB

Richmond Brothers Portfolio holdings

AUM $150M
1-Year Est. Return 14.02%
This Fund
S&P 500
This Quarter Est. Return
+5.5%
1 Year Est. Return
+14.02%
3 Year Est. Return
+102.97%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$50.6M
AUM Growth
-$3.39M
Cap. Flow
-$5.44M
Cap. Flow %
-10.75%
Top 10 Hldgs %
92.1%
Holding
26
New
2
Increased
3
Reduced
11
Closed
4

Top Buys

Rank Stock Value
1
DRRX
DURECT Corp
DRRX
+$357K
2
ALVO icon
Alvotech
ALVO
+$187K
3
HRTX icon
Heron Therapeutics
HRTX
+$184K
4
TQQQ icon
ProShares UltraPro QQQ
TQQQ
+$110K
5
SOFI icon
SoFi Technologies
SOFI
+$71.1K

Top Sells

Rank Stock Value
1
ARKK icon
ARK Innovation ETF
ARKK
+$1.58M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$1.47M
3
MDXG icon
MiMedx Group
MDXG
+$1.26M
4
AAPL icon
Apple
AAPL
+$444K
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$389K

Sector Composition

Rank Sector Weight
1 Healthcare 21.23%
2 Technology 15.58%
3 Financials 10.38%
4 Consumer Discretionary 1.55%
5 Communication Services 0.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QQQ icon
1
Invesco QQQ Trust
QQQ
$453B
$18.5M 36.67%
38,703
-3,269
-8% -$1.47M
MDXG icon
2
MiMedx Group
MDXG
$602M
$6.36M 12.57%
917,343
-179,673
-16% -$1.26M
AAPL icon
3
Apple
AAPL
$4.54T
$5.85M 11.56%
27,758
-2,381
-8% -$444K
BRK.B icon
4
Berkshire Hathaway Class B
BRK.B
$1.1T
$5.18M 10.25%
12,742
-951
-7% -$389K
GOF icon
5
Guggenheim Strategic Opportunities Fund
GOF
$2.23B
$4.43M 8.75%
296,824
-5,283
-2% -$77K
MSFT icon
6
Microsoft
MSFT
$3.45T
$2.03M 4.02%
4,544
-577
-11% -$244K
DRRX
7
DELISTED
DURECT Corp
DRRX
$1.38M 2.74%
1,072,014
+303,670
+40% +$357K
HRTX icon
8
Heron Therapeutics
HRTX
$93.9M
$1.25M 2.47%
356,558
+59,852
+20% +$184K
IBB icon
9
iShares Biotechnology ETF
IBB
$9.34B
$1M 1.98%
7,290
-959
-12% -$128K
NVG icon
10
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.68B
$549K 1.08%
44,024
-1,826
-4% -$21.8K
TQQQ icon
11
ProShares UltraPro QQQ
TQQQ
$32.1B
$544K 1.08%
14,746
+3,520
+31% +$110K
AMZN icon
12
Amazon
AMZN
$2.92T
$541K 1.07%
2,797
– –
IVV icon
13
iShares Core S&P 500 ETF
IVV
$878B
$494K 0.98%
902
-6
-0.7% -$3.15K
RMTI icon
14
Rockwell Medical
RMTI
$28.4M
$487K 0.96%
27,683
-4,542
-14% -$76.9K
GOOG icon
15
Alphabet (Google) Class C
GOOG
$4.36T
$364K 0.72%
1,984
– –
AXNX
16
DELISTED
Axonics, Inc. Common Stock
AXNX
$319K 0.63%
4,749
– –
IRD
17
Opus Genetics
IRD
$306M
$293K 0.58%
191,304
-36,157
-16% -$62.5K
APLT
18
DELISTED
Applied Therapeutics
APLT
$289K 0.57%
61,827
– –
MCD icon
19
McDonald's
MCD
$192B
$242K 0.48%
948
– –
ONCT
20
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$188K 0.37%
24,696
– –
ALVO icon
21
Alvotech
ALVO
$1.39B
$170K 0.34%
+13,966
New +$187K
SOFI icon
22
SoFi Technologies
SOFI
$21B
$66.6K 0.13%
+10,083
New +$71.1K
AIRI icon
23
Air Industries Group
AIRI
$13M
– –
-34,805
Closed -$164K
ARKK icon
24
ARK Innovation ETF
ARKK
$5.64B
– –
-31,639
Closed -$1.58M
PG icon
25
Procter & Gamble
PG
$336B
– –
-1,293
Closed -$210K
1
2

Similar funds

CRIG
Charter Research & Investment Group Southport, Connecticut $150M AUM 28.05% 1-Year Est. Return
RPA
Redwood Park Advisors Redwood City, California $150M AUM 11.34% 1-Year Est. Return
GA
Gordian Advisors Tucson, Arizona $150M AUM 15.35% 1-Year Est. Return
MPW
Magnolia Private Wealth Philadelphia, Pennsylvania $150M AUM 18.29% 1-Year Est. Return
JIM
JCP Investment Management Houston, Texas $150M AUM 19.22% 1-Year Est. Return
PAYA
Phil A. Younker & Associates Fairbanks, Alaska $150M AUM 9.85% 1-Year Est. Return
FC
FACT Capital New York $150M AUM 53.4% 1-Year Est. Return
PCMNC
Piedmont Capital Management (North Carolina) Greensboro, North Carolina $150M AUM

Richmond Brothers's Q2 2024 Portfolio in Review

As of Q2 2024, Richmond Brothers held 26 positions worth $50.6M, down 6.3% from $54M the previous quarter. Its ten largest holdings account for 92% of the portfolio.

Richmond Brothers withdrew a net $5.44M in Q2 2024, closing 4 positions and reducing 11 holdings. Its most notable exit was ARK Innovation ETF, an estimated $1.58M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 23% a quarter earlier, followed by Technology and Financials.

Against the trend, Richmond Brothers opened a new position in Alvotech worth $170K.

  • Richmond Brothers's largest Q2 2024 buy was Alvotech: 13,966 shares worth $170K.
  • Richmond Brothers added most to DURECT Corp in Q2 2024, an estimated $357K increase.
  • Richmond Brothers's biggest Q2 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.47M.
  • Richmond Brothers fully exited ARK Innovation ETF in Q2 2024, selling an estimated $1.58M.
  • Richmond Brothers's ten largest holdings make up 92% of its $50.6M portfolio in Q2 2024.
  • Richmond Brothers opened 2 new positions and closed 4 in Q2 2024.
  • Richmond Brothers's portfolio value fell 6.3% quarter-over-quarter to $50.6M.

Based on Richmond Brothers's 13F filing for Q2 2024, filed 12 Aug 2024.